Article
Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.
Cancer medicine - 1 Jan 2018
Reinbolt Raquel E, Sonis Stephen, Timmers Cynthia D, Fernández-Martínez Juan Luis, Cernea Ana, de Andrés-Galiana Enrique J, Hashemi Sepehr, Miller Karin, Pilarski Robert, Lustberg Maryam B
Abstract excerpt
Many breast cancer (BC) patients treated with aromatase inhibitors (AIs) develop aromatase inhibitor-related arthralgia (AIA). Candidate gene studies to identify AIA risk are limited in scope. We evaluated the potential of a novel analytic algorithm (NAA) to predict AIA using germline single nucleotide polymorphisms (SNP) data obtained before treatment initiation. Systematic chart review of 700 AI-treated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
